Latest Alzheimer's Stories
New platform will link eligible candidates to clinical trials around the world WASHINGTON, Feb.
Takeda will advance the CEOi's goal of building global momentum behind the G8's 2025 commitments WASHINGTON, Feb.
Home Instead to advance global momentum triggered by G8 Dementia Summit to improve care for families touched by Dementia WASHINGTON, Feb.
Eli Lilly, the Sole Competitor in 2013, Will Be Joined by GE Healthcare, Piramal Enterprises and Navidea Biopharmaceuticals in the Next Few Years, According to Findings from Decision Resources Group
HARRISBURG, Pa., Feb.
Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb.
Clinical research team meets with principal investigators in St Petersburg as a clinical trial of the first tau aggregation inhibitor (TAI) in Phase 3, aimed at halting the progression of Alzheimer's,
BOSTON, Jan. 9, 2014 /PRNewswire/ -- Akili Interactive Labs Inc. ("Akili") announced today that it has entered into an agreement with Pfizer Inc.
Clinical research centers added to allow more patients to access a tau-based investigational treatment for mild to moderate Alzheimer's disease ABERDEEN, Scotland, Jan.
- To give a box on the ear to.